Health and Healthcare
5864 Articles
Inotek Pharmaceuticals Corp. has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
Oppenheimer has released its list of potential post-election winners in the medical device industry.
Credit Suisse released its first edition of the "Credit Suisse Biosimilars 101" series of notes, offering analysis and impact of…
MannKind reported its third-quarter financial results on Monday morning.
The FDA gave Geron some good news Monday morning when it removed the clinical hold on the its investigational new…
In the wake of a reported net loss on disappointing sales of its lead product, Aegerion Pharmaceuticals shares lost a…
Lakeland.comLakeland Industries Inc. (NASDAQ: LAKE) gave an update Thursday on its business activity in the wake of the Ebola crisis.…
A new research note from Cowen focuses on health care companies that have released earnings and offer investors reasons to…
The analysts at Piper Jaffray are very positive on four top specialty pharmaceutical stocks with potential for a strong fourth-quarter…
Gilead Sciences reported disappointing third-quarter results after the market close on Monday.
Gilead Sciences is set to report its third-quarter earnings after the U.S. markets close on Tuesday.
Amgen reported better-than-expected third-quarter 2014 results after markets closed Monday afternoon.
Durect and Pain Therapeutics have been stung by Pfizer's decision to discontinue to develop Remoxy.
Sarepta Therapeutics shares took a big hit on Monday morning as disappointing news started its week out on the wrong…
Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.
Our top personal finance-related articles today. Your wallet will thank you later.